By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Verona Pharma 

Suite 21 - Alpha House
100 Borough High Street
London    SE1 1LB  United Kingdom
Phone: 44-0-20-7863-3300 Fax: 44-0-20-7863-3314



Life Sciences

Company News
Verona Pharma (VRP.L) Announces Closing Of Exercise Of Underwriters’ Over-Allotment Option 5/19/2017 7:54:28 AM
Verona Pharma (VRP.L) Announces Closing Of Global Offering 5/3/2017 11:11:55 AM
Verona Pharma (VRP.L) Release: Grant Of Options And RSUs And PDMR Dealings 5/3/2017 10:13:58 AM
Citi Appointed Depositary Bank For Verona Pharma (VRP.L)’s ADR Programme 5/3/2017 5:22:34 AM
Verona Pharma (VRP.L) Announces Pricing Of Global Offering And Approval To List On The NASDAQ Global Market 4/27/2017 10:52:16 AM
Verona Pharma (VRP.L) Plans To Conduct Registered Initial Public Offering In The U.S. 11/23/2016 1:54:34 PM
Verona Pharma (VRP.L) Rakes in $63.3 Million to Help Progress COPD Candidate RPL554 6/21/2016 6:11:21 AM
Verona Pharma (VRP.L) Announces Positive Results From "Add-On" Phase II Trial With RPL554 5/10/2016 11:06:30 AM
Verona Pharma (VRP.L) Release: Paper Demonstrating That RPL554 Enhances CTFR Activation In Cystic Fibrosis Airway Epithelia Published In American Journal Of Physiology 11/11/2015 10:06:02 AM
Verona Pharma (VRP.L) Release: Completion Of Patient Enrolment In Two RPL554 Phase IIa Studies, Ahead Of Expected Timeline 11/5/2015 11:29:25 AM